Mark D. Rothmann
Impact in
- Statistics and Probability top 1%
- Statistical Methods in Clinical Trials
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Papers in ⓘ
-
- Statistical Methods in Clinical Trials 21
- Advanced Causal Inference Techniques 7
- Statistical Methods and Inference 6
- Statistical Methods and Bayesian Inference 5
-
- Health Systems, Economic Evaluations, Quality of Life 10
- Co-authors
- Richard Pazdur (11 shared papers)Thomas R. Fleming (6 shared papers)Gang Chen (3 shared papers)Jogarao Gobburu (4 shared papers)Hong Lü (2 shared papers)Atiqur Rahman (4 shared papers)Hsiao‐Hui Tsou (2 shared papers)Martin H. Cohen (3 shared papers)
- Journals
- Journal of Biopharmaceutical Statistics (6 papers)Clinical Cancer Research (5 papers)Pharmaceutical Statistics (4 papers)Statistics in Biopharmaceutical Research (3 papers)Journal of Theoretical Probability (3 papers)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Mark D. Rothmann
40 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 125
- Statistics and Probability 382
- Hematology 508
- Genetics 373
- Gastroenterology 127
- Oncology 443
Countries citing papers authored by Mark D. Rothmann
This map shows the geographic impact of Mark D. Rothmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Rothmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Rothmann more than expected).
Fields of papers citing papers by Mark D. Rothmann
This network shows the impact of papers produced by Mark D. Rothmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Rothmann. The network helps show where Mark D. Rothmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Rothmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. | 2002 | 387 |
| 2 | Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. | 2002 | 198 |
| 3 | 2013 | 198 | |
| 4 | 2002 | 179 | |
| 5 | 2009 | 131 | |
| 6 | 2012 | 107 | |
| 7 | Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. | 2003 | 83 |
| 8 | 2011 | 82 | |
| 9 | 2013 | 73 | |
| 10 | 2010 | 69 | |
| 11 | 2008 | 68 | |
| 12 | 2011 | 55 | |
| 13 | 2015 | 41 | |
| 14 | 2011 | 32 | |
| 15 | 2008 | 31 | |
| 16 | 2012 | 26 | |
| 17 | 2003 | 15 | |
| 18 | 2022 | 10 | |
| 19 | 1998 | 10 | |
| 20 | 2022 | 10 |
About Mark D. Rothmann
Mark D. Rothmann is a scholar working on Statistics and Probability, Economics and Econometrics, Hematology, Genetics and Mathematical Physics, having authored 46 papers that have together received 1.9k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (21 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Advanced Causal Inference Techniques (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Statistical Methods and Inference (6 papers), Statistical Methods and Bayesian Inference (5 papers) and Stochastic processes and statistical mechanics (5 papers). The work is most often cited by research in Statistics and Probability (382 citations), Hematology (508 citations), Genetics (373 citations), Gastroenterology (127 citations) and Oncology (443 citations). Mark D. Rothmann has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Richard Pazdur, Thomas R. Fleming, Gang Chen, Jogarao Gobburu, Hong Lü, Atiqur Rahman, Hsiao‐Hui Tsou, Martin H. Cohen, John R. Johnson and Ning Li. Their work appears in journals such as Journal of Biopharmaceutical Statistics, Clinical Cancer Research, Pharmaceutical Statistics, Statistics in Biopharmaceutical Research and Journal of Theoretical Probability.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.